The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, September 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 3, 2025 the Company sold 13 400 (thirteen thousand four hundred) treasury shares representing 0.002% of the share capital of the Company, at a total value of BGN 36 335.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.71.
Sofia, Bulgaria, September 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 2, 2025 the Company sold 9 890 (nine thousand eight hundred and ninety) treasury shares representing 0.002% of the share capital of the Company, at a total value of BGN 26 542.10 on the Bulgarian Stock Exchange, the average price per share was BGN 2.68.
Sofia, Bulgaria, September 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 1, 2025 the Company sold 56 195 (fifty-six thousand one hundred and ninety-five) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 148 544.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.64.
Sofia, Bulgaria, September 1, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 29, 2025 the Company sold 94 677 (ninety-four thousand and six hundred seventy-seven) treasury shares representing 0.02% of the share capital of the Company, at a total value of BGN 239 619.89 on the Bulgarian Stock Exchange, the average price per share was BGN 2.53.
Sofia, Bulgaria, August 29, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 28, 2025 the Company sold 62 700 (sixty-two thousand and seven hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 156 660.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.